Description: E-Labeling, or providing labeling information through an alternative, electronic route, is a growing topic among Pharmaceutical and Medical Device companies. E-Labeling is seen by some organizations as an advantageous way to drive efficiencies and decrease costs associated with labeling. However, careful consideration of these advantages against potential risks or pitfalls should be carefully examined by organizations prior to pursuing an e-labeling initiative.
This session will provide attendees with an overview to e-labeling and explore the current regulatory framework for e-labeling around the globe, as well as recent developments in e-labeling. Following this overview, the session will dive into some of the initial considerations that organizations should consider when pursuing e-labeling, including Regulatory, Quality Assurance, and Manufacturing considerations. These considerations will help attendees identify watch-outs and better assess the pros and cons to e-label implementation.
The discussion will then turn over to the attendees to share their perspectives on e-labeling including any successes or challenges implementing e-labeling implementation within attendees organizations’, and thoughts on the future of e-labeling, given recent developments, including limited use of e-Labeling in the EU for COVID-19 vaccinations.
Learning Objectives:
Understand the emerging Regulatory framework around e-labeling
Enumerate the potential advantages and watch-outs of implementing e-labeling
Understand industry peers’ attitudes and thoughts on the future of e-labeling